Fluicell AB engages in the provision of fluid platforms for multi-functional pipettes for cell-based pharmacology research. Its products include Biopen Prime and Flex, Dynaflow Resolve, and Biopixlas. The company was founded by Aldo Jesorka, Alar Ainla, and Gavin David Michael Jeffries on January 2, 2012 and is headquartered in Molndal, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company